Table 1:
Patient Age (y) | Patient Gender | Tissue Origin | SF-1 Status | Ki-67 Labeling Index | TP53 Status | CTNNB1 Status | Secr. Funct. | Ass. Syndromes | |
---|---|---|---|---|---|---|---|---|---|
NCI-H295R | 48 | Female | Primary ACC | ++ | ≈50 % | c.782+1_994–1del62740 | p.S45P | F | Unknown |
SJ-ACC3 | 11 | Male | Primary pediatric ACC | ++++++ | ≈33–60 % | p. G254C | WT | Li-Fraumeni | |
MUC-1 | 24 | Male | Neck metastasis | +++ | ≈30 % | p.R210fs | WT | F | None |
CU-ACC1 | 66 | Female | Perinephric metastasis | +++ | ≈33–60 % | WT | p.G34R | F | |
CU-ACC2 | 26 | Female | Liver metastasis | + | ≈33–60 % | p.G245S | WT | NF | Lynch (Loss of MSH2) |